Search

Search Constraints

You searched for: Author/Creator Mueller, M.

Search Results

32. The TBL1 inhibitor, Tegavivint, suppresses tumour growth and enhances T-cell infiltration in preclinical murine β-Catenin mutant hepatocellular carcinoma. (October 2022)